查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2065188

醫療保健數據分析市場預測至2034年—按類型、組件、部署模式、交付模式、應用、最終用戶和地區分類的全球分析

Healthcare Data Analytics Market Forecasts to 2034 - Global Analysis By Type, Component, Deployment Model, Delivery Model, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球醫療保健數據分析市場預計將在 2026 年達到 274 億美元，到 2034 年達到 987 億美元，在預測期內以 17.3% 的複合年成長率成長。

醫療數據分析是指利用先進的統計、計算和機器學習調查方法，系統地收集、處理和解釋臨床、財務和營運方面的醫療數據。這使醫療機構能夠獲得可操作的見解，從而改善患者預後、提高資源利用率、檢測詐欺行為、支持社區健康促進計劃並製定策略規劃。

醫療數據的激增以及對實證臨床決策日益成長的需求

電子健康記錄、醫學影像檔案、基因組資料集和真實世界證據（RWE）來源的指數級成長，使得整個醫療保健產業對分析的需求空前高漲。臨床醫生、管理人員和保險公司越來越依賴數據分析平台，從這些龐大且異質的數據儲存庫中提取可操作的見解。促進互通性和基於結果的補償機制的法律規範，進一步提升了數據驅動型醫療服務的策略優先順序。隨著精準醫療計畫的日益普及和慢性病管理的個人化程度不斷提高，醫療機構正在加大對分析的投入，以支持預防性干預策略，並展現可衡量的臨床和經濟價值。

資料孤島、互通性障礙和醫療資訊基礎設施碎片化。

儘管電子健康記錄的普及率不斷提高，但醫療保健數據仍然嚴重分散，涉及不相容的系統、專有格式和各自獨立的醫療機構。缺乏通用數據標準以及HL7、FHIR等互通性框架的實施不完善，阻礙了全面患者資料集的聚合，而這對於進行有意義的人群層面分析至關重要。醫院和診所的傳統IT基礎設施進一步限制了資料管道的效率和即時分析能力。這些結構性障礙增加了實施分析的技術複雜性和成本，尤其對於缺乏財力和人力資源來獨立克服互通性挑戰的區域醫療保健系統和安全網提供者而言。

將人工智慧與真實世界數據分析結合應用於藥物研發

製藥和生物技術公司正擴大採用醫療數據分析平台，以加速臨床試驗設計、識別患者群體並產生真實世界證據，從而支持監管申報和上市後監測。人工智慧驅動的分析平台能夠實現新型生物標記發現和患者分層方法，從而降低試驗脫落率和研發成本。健康保險公司也正在利用預測分析來最佳化風險調整、識別高成本患者群體並設計有針對性的護理管理干預措施。

更嚴格的資料隱私法規和日益複雜的病患知情同意管理。

隨著全球資料隱私法規的擴展和加強，醫療資料分析營運面臨合規性方面的挑戰。 HIPAA（健康保險流通與責任法案）的執法措施、GDPR（一般資料保護規則）的要求以及亞太地區不斷發展的資料保護法律，都對收集和分析病患健康資訊的機構施加了重大的合規義務。在多方資料共用框架下管理不斷變化的患者同意設置，增加了營運的複雜性，並可能損害分析資料集的完整性。公眾對醫療數據商業用途的擔憂，可能會削弱患者信任，限制患者參與醫療數據項目，降低可用於分析的資料集的豐富度，並最終限制分析的深度和普適性。

新型冠狀病毒（COVID-19）的影響：

新冠疫情大大提升了醫療數據分析的戰略意義，凸顯了其在疫情監測、醫院容量管理和疫苗分配規劃中的關鍵作用。世界各國政府和衛生部門迅速投資分析平台，以追蹤感染趨勢、模擬醫療系統負荷並分配治療資源。疫情也加速了醫療記錄的數位化進程，擴大了真實世界數據的生成，並為疫情後的研究創建了更豐富的分析資料集。在疫情期間建立了強大分析能力的醫療機構，如今正利用這些投資來應對更廣泛的臨床和營運挑戰，從而在疫情後時期保持強勁的市場成長勢頭。

在預測期內，臨床分析領域預計將佔據最大的市場佔有率。

預計在預測期內，臨床分析領域將佔據最大的市場佔有率。這主要歸功於醫療服務提供者積極投資於有助於提高醫療品質、監測病人安全和最佳化臨床路徑的工具。醫院和綜合醫療網路正在部署臨床分析平台，以減少再入院率、提高敗血症檢測的準確性並最佳化手術安排。精準醫療計畫的日益普及（這些計畫需要整合基因組和生物標記數據）進一步擴大了臨床分析的應用範圍。

預計在預測期內，營運分析領域將呈現最高的複合年成長率。

在預測期內，營運分析領域預計將呈現最高的成長率，反映出醫療機構日益重視供應鏈韌性、人員配置最佳化和設施利用效率。醫院正擴大採用即時運作儀錶板來管理病患流量、縮短急診等待時間，並根據入院模式預測人員需求。疫情後的營運中斷進一步鞏固了數據驅動型資源管理在整個醫療網路中的策略價值。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其龐大的電子健康記錄(EHR) 部署基礎、先進的交換醫療資訊基礎設施以及高度集中的分析解決方案供應商。美國是該地區需求的主要驅動力，這主要源於綜合醫療保健系統、健康保險公司和製藥公司為尋求真實世界數據 (RWE) 和人群健康管理能力而進行的大規模部署。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於醫療保健的快速數位化、政府主導的國家健康數據平台計劃，以及人們日益認知到分析作為提升醫療系統效率的戰略要素的重要性。中國、印度、日本和韓國正在大力投資國家健康數據基礎設施和精準醫療項目，這些項目都需要先進的分析能力。數位醫療新創企業的壯大以及全球供應商在該地區日益深入的佈局，正在加速解決方案的交付和應用。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球醫療保健資料分析市場：按類型分類

  • 說明分析
  • 預測分析
  • 指示性分析
  • 診斷分析
  • 認知分析

第6章 全球醫療保健資料分析市場：按組件分類

  • 軟體
    • 資料管理軟體
    • 報告創建和視覺化工具
    • AI/ML 分析平台
  • 硬體
  • 服務

第7章：全球醫療保健資料分析市場：依部署模式分類

  • 現場
  • 基於雲端的
  • 混合

第8章：全球醫療保健數據分析市場：依交付模式分類

  • 獨立解決方案
  • 整合解決方案

第9章 全球醫療保健資料分析市場：按應用領域分類

  • 臨床分析
  • 財務分析
  • 營運分析
  • 人口健康分析
  • 收入週期管理分析
  • 詐欺偵測和風險管理
  • 精準醫療分析
  • 供應鏈分析

第10章：全球醫療保健數據分析市場：按最終用戶分類

  • 醫院和診所
  • 醫療保健支付方
  • 製藥和生物技術公司
  • 學術研究機構
  • 政府附屬醫療機構
  • 門診部
  • 診斷檢查室

第11章 全球醫療保健資料分析市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Optum
  • IQVIA
  • Oracle Corporation
  • SAS Institute Inc.
  • Health Catalyst
  • Cognizant Technology Solutions
  • Merative
  • Veradigm
  • MedeAnalytics
  • Arcadia
  • GE HealthCare
  • Siemens Healthineers
  • McKesson Corporation
  • Wipro Limited
  • Infor
Product Code: SMRC36772

According to Stratistics MRC, the Global Healthcare Data Analytics Market is accounted for $27.4 billion in 2026 and is expected to reach $98.7 billion by 2034, growing at a CAGR of 17.3% during the forecast period. Healthcare Data Analytics encompasses the systematic collection, processing, and interpretation of clinical, financial, and operational healthcare data using advanced statistical, computational, and machine learning methodologies. It enables healthcare organizations to derive actionable insights for improving patient outcomes, enhancing resource utilization, identifying fraud, supporting population health initiatives, and informing strategic planning.

Market Dynamics:

Driver:

Surging volume of healthcare data and growing demand for evidence-based clinical decision-making

The exponential growth of electronic health records, medical imaging files, genomic datasets, and real-world evidence sources is creating an unprecedented analytical imperative across the healthcare sector. Clinicians, administrators, and payers are increasingly relying on data analytics platforms to extract actionable intelligence from these vast, heterogeneous data repositories. Regulatory frameworks promoting interoperability and outcomes-based reimbursement are further elevating the strategic priority of data-driven care delivery. As precision medicine programs proliferate and chronic disease management becomes more personalized, healthcare organizations are scaling their analytics investments to support proactive intervention strategies and demonstrate measurable clinical and financial value.

Restraint:

Data silos, interoperability barriers, and fragmented health information infrastructure

Despite widespread electronic health record adoption, healthcare data remains severely fragmented across incompatible systems, proprietary formats, and disconnected care settings. The lack of universal data standards and incomplete implementation of interoperability frameworks such as HL7 FHIR impede the aggregation of comprehensive patient datasets needed for meaningful population-level analytics. Legacy IT infrastructure in hospitals and clinics further limits data pipeline efficiency and real-time analytical capabilities. These structural barriers elevate the technical complexity and cost of analytics deployments, particularly for community health systems and safety-net providers that lack the financial and human resources to overcome interoperability challenges independently.

Opportunity:

Integration of artificial intelligence and real-world evidence analytics in drug development

Pharmaceutical and biotechnology companies are increasingly deploying healthcare data analytics platforms to accelerate clinical trial design, identify patient cohorts, and generate real-world evidence supporting regulatory submissions and post-market surveillance. AI-powered analytics platforms are enabling novel biomarker discovery and patient stratification approaches that reduce trial attrition and development costs. Healthcare payers are also leveraging predictive analytics to optimize risk adjustment, identify high-cost patient segments, and design targeted care management interventions.

Threat:

Escalating data privacy regulations and patient consent management complexities

Healthcare data analytics operations face mounting compliance challenges as data privacy regulations proliferate and tighten globally. The evolving landscape of HIPAA enforcement actions, GDPR requirements, and emerging national data protection laws in Asia Pacific impose substantial compliance obligations on organizations aggregating and analyzing patient health information. Managing dynamic patient consent preferences across multi-party data sharing arrangements adds operational complexity that can restrict the completeness of analytical datasets. Public concern about secondary uses of health data for commercial purposes risks eroding patient trust, potentially limiting participation in health data programs and reducing the richness of datasets available for analytics, ultimately constraining analytical depth and generalizability.

Covid-19 Impact:

The COVID-19 pandemic dramatically elevated the strategic profile of healthcare data analytics by demonstrating its critical role in epidemic surveillance, hospital capacity management, and vaccine distribution planning. Governments and health authorities worldwide rapidly invested in analytics platforms to track case trends, model healthcare system strain, and allocate therapeutic resources. The pandemic also accelerated the digitization of clinical records and expanded real-world data generation, creating richer analytical datasets for post-pandemic research. Healthcare organizations that built robust analytics capabilities during the crisis are now leveraging these investments to address broader clinical and operational challenges, sustaining elevated market growth momentum in the post-pandemic period.

The clinical analytics segment is expected to be the largest during the forecast period

The clinical analytics segment is expected to account for the largest market share during the forecast period, driven by intensive healthcare provider investment in tools that support care quality improvement, patient safety monitoring, and clinical pathway optimization. Hospitals and integrated delivery networks are deploying clinical analytics platforms to reduce readmissions, enhance sepsis detection, and optimize surgical scheduling. The growing adoption of precision medicine programs requiring genomic and biomarker data integration is further expanding the clinical analytics deployment footprint.

The operational analytics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the operational analytics segment is predicted to witness the highest growth rate, reflecting escalating healthcare organization focus on supply chain resilience, workforce optimization, and facility utilization efficiency. Hospitals are increasingly deploying real-time operational dashboards to manage patient flow, reduce emergency department wait times, and predict staffing needs based on admission patterns. Post-pandemic operational disruptions have reinforced the strategic value of data-driven resource management across healthcare networks.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, anchored by the region's extensive EHR adoption base, advanced health information exchange infrastructure, and high concentration of analytics solution vendors. The United States drives the majority of regional demand through large-scale deployments by integrated health systems, health plans, and pharmaceutical companies pursuing real-world evidence and population health management capabilities.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rapid healthcare digitization, government-led national health data platform initiatives, and the growing recognition of analytics as a strategic enabler of healthcare system efficiency. China, India, Japan, and South Korea are investing significantly in national health data infrastructure and precision medicine programs that require sophisticated analytics capabilities. The expanding base of digital health startups and the deepening presence of global analytics vendors in the region are accelerating solution availability and adoption.

Key players in the market

Some of the key players in Healthcare Data Analytics Market include Optum, IQVIA, Oracle Corporation, SAS Institute Inc., Health Catalyst, Cognizant Technology Solutions, Merative, Veradigm, MedeAnalytics, Arcadia, GE HealthCare, Siemens Healthineers, McKesson Corporation, Wipro Limited, and Infor.

Key Developments:

In February 2026, IQVIA announced the expansion of its Orchestrated Analytics platform with new AI-powered cohort identification and real-world evidence generation modules targeting pharmaceutical companies conducting post-market surveillance and clinical trial optimization. The update integrates de-identified patient data from over 100 million patient records across the United States and European healthcare systems.

In January 2026, Health Catalyst announced a strategic acquisition of a clinical AI analytics firm specializing in sepsis prediction and clinical deterioration detection algorithms. The acquisition expands Health Catalyst's suite of patient safety analytics solutions and strengthens its position in the hospital and acute care analytics market across North America and select international markets.

Types Covered:

  • Descriptive Analytics
  • Predictive Analytics
  • Prescriptive Analytics
  • Diagnostic Analytics
  • Cognitive Analytics

Components Covered:

  • Software
  • Hardware
  • Services

Deployment Modes Covered:

  • On-Premises
  • Cloud-Based
  • Hybrid

Delivery Models Covered:

  • Standalone Solutions
  • Integrated Solutions

Applications Covered:

  • Clinical Analytics
  • Financial Analytics
  • Operational Analytics
  • Population Health Analytics
  • Revenue Cycle Management Analytics
  • Fraud Detection & Risk Management
  • Precision Medicine Analytics
  • Supply Chain Analytics

End Users Covered:

  • Hospitals & Clinics
  • Healthcare Payers
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Government Healthcare Organizations
  • Ambulatory Care Centers
  • Diagnostic Laboratories

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Healthcare Data Analytics Market, By Type

  • 5.1 Descriptive Analytics
  • 5.2 Predictive Analytics
  • 5.3 Prescriptive Analytics
  • 5.4 Diagnostic Analytics
  • 5.5 Cognitive Analytics

6 Global Healthcare Data Analytics Market, By Component

  • 6.1 Software
    • 6.1.1 Data Management Software
    • 6.1.2 Reporting & Visualization Tools
    • 6.1.3 AI & ML Analytics Platforms
  • 6.2 Hardware
  • 6.3 Services

7 Global Healthcare Data Analytics Market, By Deployment Mode

  • 7.1 On-Premises
  • 7.2 Cloud-Based
  • 7.3 Hybrid

8 Global Healthcare Data Analytics Market, By Delivery Model

  • 8.1 Standalone Solutions
  • 8.2 Integrated Solutions

9 Global Healthcare Data Analytics Market, By Application

  • 9.1 Clinical Analytics
  • 9.2 Financial Analytics
  • 9.3 Operational Analytics
  • 9.4 Population Health Analytics
  • 9.5 Revenue Cycle Management Analytics
  • 9.6 Fraud Detection & Risk Management
  • 9.7 Precision Medicine Analytics
  • 9.8 Supply Chain Analytics

10 Global Healthcare Data Analytics Market, By End User

  • 10.1 Hospitals & Clinics
  • 10.2 Healthcare Payers
  • 10.3 Pharmaceutical & Biotechnology Companies
  • 10.4 Academic & Research Institutes
  • 10.5 Government Healthcare Organizations
  • 10.6 Ambulatory Care Centers
  • 10.7 Diagnostic Laboratories

11 Global Healthcare Data Analytics Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Optum
  • 14.2 IQVIA
  • 14.3 Oracle Corporation
  • 14.4 SAS Institute Inc.
  • 14.5 Health Catalyst
  • 14.6 Cognizant Technology Solutions
  • 14.7 Merative
  • 14.8 Veradigm
  • 14.9 MedeAnalytics
  • 14.10 Arcadia
  • 14.11 GE HealthCare
  • 14.12 Siemens Healthineers
  • 14.13 McKesson Corporation
  • 14.14 Wipro Limited
  • 14.15 Infor

List of Tables

  • Table 1 Global Healthcare Data Analytics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Healthcare Data Analytics Market Outlook, By Type (2023-2034) ($MN)
  • Table 3 Global Healthcare Data Analytics Market Outlook, By Descriptive Analytics (2023-2034) ($MN)
  • Table 4 Global Healthcare Data Analytics Market Outlook, By Predictive Analytics (2023-2034) ($MN)
  • Table 5 Global Healthcare Data Analytics Market Outlook, By Prescriptive Analytics (2023-2034) ($MN)
  • Table 6 Global Healthcare Data Analytics Market Outlook, By Diagnostic Analytics (2023-2034) ($MN)
  • Table 7 Global Healthcare Data Analytics Market Outlook, By Cognitive Analytics (2023-2034) ($MN)
  • Table 8 Global Healthcare Data Analytics Market Outlook, By Component (2023-2034) ($MN)
  • Table 9 Global Healthcare Data Analytics Market Outlook, By Software (2023-2034) ($MN)
  • Table 10 Global Healthcare Data Analytics Market Outlook, By Data Management Software (2023-2034) ($MN)
  • Table 11 Global Healthcare Data Analytics Market Outlook, By Reporting & Visualization Tools (2023-2034) ($MN)
  • Table 12 Global Healthcare Data Analytics Market Outlook, By AI & ML Analytics Platforms (2023-2034) ($MN)
  • Table 13 Global Healthcare Data Analytics Market Outlook, By Hardware (2023-2034) ($MN)
  • Table 14 Global Healthcare Data Analytics Market Outlook, By Services (2023-2034) ($MN)
  • Table 15 Global Healthcare Data Analytics Market Outlook, By Deployment Mode (2023-2034) ($MN)
  • Table 16 Global Healthcare Data Analytics Market Outlook, By On-Premises (2023-2034) ($MN)
  • Table 17 Global Healthcare Data Analytics Market Outlook, By Cloud-Based (2023-2034) ($MN)
  • Table 18 Global Healthcare Data Analytics Market Outlook, By Hybrid (2023-2034) ($MN)
  • Table 19 Global Healthcare Data Analytics Market Outlook, By Delivery Model (2023-2034) ($MN)
  • Table 20 Global Healthcare Data Analytics Market Outlook, By Standalone Solutions (2023-2034) ($MN)
  • Table 21 Global Healthcare Data Analytics Market Outlook, By Integrated Solutions (2023-2034) ($MN)
  • Table 22 Global Healthcare Data Analytics Market Outlook, By Application (2023-2034) ($MN)
  • Table 23 Global Healthcare Data Analytics Market Outlook, By Clinical Analytics (2023-2034) ($MN)
  • Table 24 Global Healthcare Data Analytics Market Outlook, By Financial Analytics (2023-2034) ($MN)
  • Table 25 Global Healthcare Data Analytics Market Outlook, By Operational Analytics (2023-2034) ($MN)
  • Table 26 Global Healthcare Data Analytics Market Outlook, By Population Health Analytics (2023-2034) ($MN)
  • Table 27 Global Healthcare Data Analytics Market Outlook, By Revenue Cycle Management Analytics (2023-2034) ($MN)
  • Table 28 Global Healthcare Data Analytics Market Outlook, By Fraud Detection & Risk Management (2023-2034) ($MN)
  • Table 29 Global Healthcare Data Analytics Market Outlook, By Precision Medicine Analytics (2023-2034) ($MN)
  • Table 30 Global Healthcare Data Analytics Market Outlook, By Supply Chain Analytics (2023-2034) ($MN)
  • Table 31 Global Healthcare Data Analytics Market Outlook, By End User (2023-2034) ($MN)
  • Table 32 Global Healthcare Data Analytics Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 33 Global Healthcare Data Analytics Market Outlook, By Healthcare Payers (2023-2034) ($MN)
  • Table 34 Global Healthcare Data Analytics Market Outlook, By Pharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 35 Global Healthcare Data Analytics Market Outlook, By Academic & Research Institutes (2023-2034) ($MN)
  • Table 36 Global Healthcare Data Analytics Market Outlook, By Government Healthcare Organizations (2023-2034) ($MN)
  • Table 37 Global Healthcare Data Analytics Market Outlook, By Ambulatory Care Centers (2023-2034) ($MN)
  • Table 38 Global Healthcare Data Analytics Market Outlook, By Diagnostic Laboratories (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.